TickerFactsScreenerDevelopers

Kalaris Therapeutics, Inc. (KLRS) — Operating Cash Flow

Annual figures by fiscal year, from SEC filings.

2019: -$20.16M2020: -$60.81M2021: -$106.32M2022: -$142.05M2023: -$124.45M2024: -$20.67M2025: -$38.37M-$38.37M
2019Operating Cash Flow (USD)2025
Fiscal YearOperating Cash FlowChange YoY
2025-$38.37M-85.6%
2024-$20.67M+83.4%
2023-$124.45M+12.4%
2022-$142.05M-33.6%
2021-$106.32M-74.8%
2020-$60.81M-201.7%
2019-$20.16M—